BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Liu X, Tian L, Chen Y. Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections. Clin Rev Allergy Immunol. 2016;50:41-54. [PMID: 25480494 DOI: 10.1007/s12016-014-8465-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Ribeiro CRA, Beghini DG, Lemos AS, Martinelli KG, de Mello VDM, de Almeida NAA, Lewis-Ximenez LL, de Paula VS. Cytokines profile in patients with acute and chronic hepatitis B infection. Microbiol Immunol 2021. [PMID: 34647645 DOI: 10.1111/1348-0421.12947] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang Q, Sun X, Huang X, Huang J, Hasan MW, Yan R, Xu L, Song X, Li X. Nanoparticles of Chitosan/Poly(D,L-Lactide-Co-Glycolide) Enhanced the Immune Responses of Haemonchus contortus HCA59 Antigen in Model Mice. Int J Nanomedicine 2021;16:3125-39. [PMID: 33981142 DOI: 10.2147/IJN.S301851] [Reference Citation Analysis]
3 Sy BT, Hoan NX, Tong HV, Meyer CG, Toan NL, Song LH, Bock CT, Velavan TP. Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection. World J Gastroenterol 2018; 24(2): 248-256 [PMID: 29375210 DOI: 10.3748/wjg.v24.i2.248] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lian M, Selmi C, Gershwin ME, Ma X. Myeloid Cells and Chronic Liver Disease: a Comprehensive Review. Clin Rev Allergy Immunol. 2018;54:307-317. [PMID: 29313221 DOI: 10.1007/s12016-017-8664-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Ye B, Liu X, Li X, Kong H, Tian L, Chen Y. T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. Cell Death Dis. 2015;6:e1694. [PMID: 25789969 DOI: 10.1038/cddis.2015.42] [Cited by in Crossref: 162] [Cited by in F6Publishing: 153] [Article Influence: 23.1] [Reference Citation Analysis]
6 Zhang BY, Chai DP, Wu YH, Qiu LP, Zhang YY, Ye ZH, Yu XP. Potential Drug Targets Against Hepatitis B Virus Based on Both Virus and Host Factors. Curr Drug Targets 2019;20:1636-51. [PMID: 31362671 DOI: 10.2174/1389450120666190729115646] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tsai JF, Chen SC, Lin ZY, Dai CY, Huang JF, Yu ML, Chuang WL. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B. Kaohsiung J Med Sci 2017;33:453-7. [PMID: 28865603 DOI: 10.1016/j.kjms.2017.04.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
8 Maizels RM. The multi-faceted roles of TGF-β in regulation of immunity to infection. Adv Immunol 2021;150:1-42. [PMID: 34176558 DOI: 10.1016/bs.ai.2021.05.001] [Reference Citation Analysis]
9 Gao YH, Li QQ, Wang CG, Sun J, Wang XM, Li YJ, He XT, Xu HQ, Niu JQ. The role of IL22 polymorphisms on liver cirrhosis in patients with hepatitis B virus: A case control study. Medicine (Baltimore) 2019;98:e17867. [PMID: 31689880 DOI: 10.1097/MD.0000000000017867] [Reference Citation Analysis]
10 Townsend EC, Zhang GY, Ali R, Firke M, Moon MS, Han MAT, Fram B, Glenn JS, Kleiner DE, Koh C, Heller T. The balance of type 1 and type 2 immune responses in the contexts of hepatitis B infection and hepatitis D infection. J Gastroenterol Hepatol. 2019;34:764-775. [PMID: 30695096 DOI: 10.1111/jgh.14617] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Teng DK, Liu Y, Lv YF, Wang L, Zhang W, Wang JP, Li Y. Elevated interleukin-35 suppresses liver inflammation by regulation of T helper 17 cells in acute hepatitis B virus infection. Int Immunopharmacol 2019;70:252-9. [PMID: 30851705 DOI: 10.1016/j.intimp.2019.02.048] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
12 Yu X, Zheng Y, Deng Y, Li J, Guo R, Su M, Ming D, Lin Z, Zhang J, Su Z. Serum Interleukin (IL)-9 and IL-10, but not T-Helper 9 (Th9) Cells, are Associated With Survival of Patients With Acute-on-Chronic Hepatitis B Liver Failure. Medicine (Baltimore) 2016;95:e3405. [PMID: 27100428 DOI: 10.1097/MD.0000000000003405] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
13 Al-Anazi MR, Matou-Nasri S, Al-Qahtani AA, Alghamdi J, Abdo AA, Sanai FM, Al-Hamoudi WK, Alswat KA, Al-Ashgar HI, Khan MQ, Albenmousa A, Shamsi MB, Alanazi SK, Dela Cruz D, Bohol MFF, Al-Ahdal MN, Al-Qahtani AA. Association between IL-37 gene polymorphisms and risk of HBV-related liver disease in a Saudi Arabian population. Sci Rep 2019;9:7123. [PMID: 31073186 DOI: 10.1038/s41598-019-42808-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
14 Cao L, Zhang T, Zhu J, Li A, Zheng K, Zhang N, Su B, Xia W, Wu H, Li N, He Q. Polymorphism of TLR5 rs5744174 is associated with disease progression in Chinese patients with chronic HBV infection. APMIS 2017;125:708-16. [PMID: 28543911 DOI: 10.1111/apm.12707] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Li X, Dong Y, Tu K, Wang W. Proteomics analysis reveals the interleukin-35-dependent regulatory mechanisms affecting CD8+ T-cell functions. Cell Immunol 2020;348:104022. [PMID: 31879030 DOI: 10.1016/j.cellimm.2019.104022] [Reference Citation Analysis]
16 Shao X, Ma J, Jia S, Yang L, Wang W, Jin Z. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection. Front Cell Infect Microbiol 2017;7:472. [PMID: 29181338 DOI: 10.3389/fcimb.2017.00472] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
17 Uluca Ü, Şen V, Ece A, Tan İ, Karabel D, Aktar F, Karabel M, Balık H, Güneş A. Serum galectin-3 levels in children with chronic hepatitis B infection and inactive hepatitis B carriers. Med Sci Monit 2015;21:1376-80. [PMID: 25968249 DOI: 10.12659/MSM.894035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
18 Kang Y, Cai Y. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy. J Hosp Infect 2017;96:342-8. [PMID: 28545829 DOI: 10.1016/j.jhin.2017.04.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
19 Hastings KL, Green MD, Gao B, Ganey PE, Roth RA, Burleson GR. Beyond Metabolism: Role of the Immune System in Hepatic Toxicity. Int J Toxicol 2020;39:151-64. [PMID: 32174281 DOI: 10.1177/1091581819898399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Goh ZY, Ren EC, Ko HL. Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B. World J Gastroenterol 2021; 27(14): 1369-1391 [PMID: 33911462 DOI: 10.3748/wjg.v27.i14.1369] [Reference Citation Analysis]
21 Xu D, Huang Y, Wang J. Gut microbiota modulate the immune effect against hepatitis B virus infection.Eur J Clin Microbiol Infect Dis. 2015;34:2139-2147. [PMID: 26272175 DOI: 10.1007/s10096-015-2464-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
22 Yang Z, Wang J, Zhang D, Wang S, Wang R, Zhao J. Hepatitis B virus infected patients show increased risk of cerebral aneurysm rupture: A retrospective analysis. J Clin Neurosci 2019;63:155-9. [PMID: 30850179 DOI: 10.1016/j.jocn.2019.01.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Cui M, Lv Y, Lu J, Zhang W, Duan Y, Huang Y, Yang L, Li M, Liu W, Liu D, Yan H. Decreased frequency of circulating Th9 cells in patients with chronic hepatitis B infection. J Clin Lab Anal 2018;32. [PMID: 28481430 DOI: 10.1002/jcla.22246] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sang X, Wang R, Han Y, Zhang C, Shen H, Yang Z, Xiong Y, Liu H, Liu S, Li R, Yang R, Wang J, Wang X, Bai Z, Xiao X. T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model. Acta Pharm Sin B 2017;7:311-8. [PMID: 28540167 DOI: 10.1016/j.apsb.2017.02.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
25 Chuai X, Xie B, Deng Y, Zhao Y, Wang W, Gao Z, Wang W, Qiu X, Tan W. HBV antigen and DNA loss from mouse serum is associated with novel vaccine-induced HBV surface antigen-specific cell-mediated immunity and cytokine production. Antiviral Res 2019;161:20-7. [PMID: 30423362 DOI: 10.1016/j.antiviral.2018.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Yamamoto Y, Kakizaki M, Shimizu T, Carreras J, Chiba T, Chamoto K, Kagawa T, Aoki T, Nakamura N, Ando K, Kotani A. PD-L1 is induced on the hepatocyte surface via CKLF-like MARVEL transmembrane domain-containing protein 6 up-regulation by the anti-HBV drug Entecavir. Int Immunol 2020;32:519-31. [PMID: 32219331 DOI: 10.1093/intimm/dxaa018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Chuai X, Chen P, Chen H, Wang W, Deng Y, Ruan L, Li W, Tan W. Protective efficacy and hepatitis B virus clearance in mice enhanced by cell-mediated immunity with novel prime-boost regimens. J Viral Hepat 2017;24:337-45. [PMID: 27885748 DOI: 10.1111/jvh.12649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
28 Li X, Liu X, Wang W. IL-35: A Novel Immunomodulator in Hepatitis B Virus-Related Liver Diseases. Front Cell Dev Biol 2021;9:614847. [PMID: 33777929 DOI: 10.3389/fcell.2021.614847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Yong YK, Tan HY, Saeidi A, Rosmawati M, Atiya N, Ansari AW, Rajarajeswaran J, Vadivelu J, Velu V, Larsson M, Shankar EM. Decrease of CD69 levels on TCR Vα7.2+CD4+ innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients. Innate Immun 2017;23:459-67. [PMID: 28606013 DOI: 10.1177/1753425917714854] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
30 Liu X, Jiao Y, Cui B, Gao X, Xu J, Zhao Y. The potential protective role of hepatitis B virus infection in pristane-induced lupus in mice. Lupus 2016;25:1180-9. [PMID: 27125291 DOI: 10.1177/0961203316631637] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
31 Xu Z, Lin JZ, Zeng YF, Yang XH, Wu ZB, Hu ZX, Zhao QY, Liu J, Gao ZL. Changes of cytokine levels and T cell surface molecules in patients with chronic hepatitis B and the association with functional cure. J Med Virol 2021;93:4966-74. [PMID: 33913556 DOI: 10.1002/jmv.27041] [Reference Citation Analysis]
32 Moore TC, Hasenkrug KJ. B-Cell Control of Regulatory T Cells in Friend Virus Infection. J Mol Biol 2021;433:166583. [PMID: 32598936 DOI: 10.1016/j.jmb.2020.06.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Mohammadzadeh S, Ofoghi H, Ebrahimi-Rad M, Ehsani P. Construction of bicistronic cassette for co-expressing hepatitis B surface antigen and mouse granulocyte-macrophage colony stimulating factor as adjuvant in tobacco plant. Pharm Biol 2019;57:669-75. [PMID: 31549887 DOI: 10.1080/13880209.2019.1662458] [Reference Citation Analysis]
34 Joshi SS, Wong D, Castillo E, Swain MG, Coffin CS. Peripartum cytokine flares in a multiethnic cohort of chronic hepatitis B carriers does not correlate with hepatitis B virus suppression or increased risk of liver disease. Am J Reprod Immunol 2017;78. [PMID: 28544232 DOI: 10.1111/aji.12707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
35 Savoji MA, Sereshgi MMA, Ghahari SMM, Asgarhalvaei F, Mahdavi M. Formulation of HBsAg in Montanide ISA 51VG adjuvant: Immunogenicity study and monitoring long-lived humoral immune responses. Int Immunopharmacol 2021;96:107599. [PMID: 33848910 DOI: 10.1016/j.intimp.2021.107599] [Reference Citation Analysis]
36 Matsumoto T, Takahashi K, Inuzuka T, Kim SK, Kurosaki T, Kawakami S, Chiba T, Seno H, Marusawa H. Activation of TNF-α-AID axis and co-inhibitory signals in coordination with Th1-type immunity in a mouse model recapitulating hepatitis B. Antiviral Res 2017;139:138-45. [PMID: 28063995 DOI: 10.1016/j.antiviral.2017.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
37 Shoraka S, Mohebbi SR, Hosseini SM, Hosseini Razavi A, Hatami Y, Sharifian A, Rostami-Nejad M, Asadzadeh Aghdaei H, Zali MR. Association between Interleukin-21 and Interleukin-21 receptor gene polymorphisms with susceptibility to chronic hepatitis B virus infection and HBV spontaneous clearance in Iranian population. Microb Pathog 2019;128:263-7. [PMID: 30639626 DOI: 10.1016/j.micpath.2019.01.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Hoan NX, Van Tong H, Giang DP, Toan NL, Meyer CG, Bock CT, Kremsner PG, Song LH, Velavan TP. Interferon-stimulated gene 15 in hepatitis B-related liver diseases. Oncotarget. 2016;7:67777-67787. [PMID: 27626177 DOI: 10.18632/oncotarget.11955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
39 Hasan MW, Haseeb M, Ehsan M, Gadahi JA, Naqvi MA, Wang QQ, Liu X, Lakho SA, Yan R, Xu L, Song X, Li X. Nanoparticles (PLGA and Chitosan)-Entrapped ADP-Ribosylation Factor 1 of Haemonchus contortus Enhances the Immune Responses in ICR Mice. Vaccines (Basel) 2020;8:E726. [PMID: 33276581 DOI: 10.3390/vaccines8040726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Cai H, Liu G, Zhong J, Zheng K, Xiao H, Li C, Song X, Li Y, Xu C, Wu H, He Z, Zhu Q. Immune Checkpoints in Viral Infections. Viruses 2020;12:E1051. [PMID: 32967229 DOI: 10.3390/v12091051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
41 Gao P, Luo Y, Chen L, Yang Z, He Q, Li J. The effect of hepatitis B virus on T lymphocyte and its subsets in chronic hepatitis B patients in different ALT stages: A new concept ALT in HBV infection. Int Immunopharmacol 2021;101:108182. [PMID: 34601330 DOI: 10.1016/j.intimp.2021.108182] [Reference Citation Analysis]
42 Van Tong H, Hoan NX, Binh MT, Quyen DT, Meyer CG, Song LH, Toan NL, Velavan TP. Interferon-stimulated gene 20 kDa protein serum levels and clinical outcome of hepatitis B virus-related liver diseases. Oncotarget 2018;9:27858-71. [PMID: 29963243 DOI: 10.18632/oncotarget.25559] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]